Small study tests best way to mix chemo for liver tumors

NCT ID NCT03706157

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 10 people with liver cancer (HCC) who were getting a standard treatment called chemoembolization (c-TACE). The goal was to see if mixing the chemotherapy drug doxorubicin with salt water or a contrast dye changes how the drug spreads inside the tumor. Researchers took small tissue samples and used special imaging to track the drug, aiming to find the best way to prepare the treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATO-CELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital, Strasbourg, france

    Strasbourg, 67000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.